Primary progressive multiple sclerosis
RecruitingOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
- Disease:Primary progressive multiple sclerosis
- Substances:–
Germany- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Germany17 clinical trials in Erbach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on early Alzheimer's disease treatments and interventions for associated psychosis. Studies are evaluating novel compounds for managing cognitive decline and neuropsychiatric symptoms.
Multiple therapeutic approaches targeting both cognitive symptoms and behavioral manifestations of the disease.
Innovative research examining new treatments for menstrual migraine and chronic migraine conditions. Comparative studies evaluating the effectiveness of different preventive treatments.
Focus on developing targeted therapies for specific types of migraines and their prevention.
Comprehensive research programs investigating treatments for various forms of multiple sclerosis, including progressive and relapsing forms. Studies utilize advanced imaging techniques to track disease progression.
Advanced therapeutic approaches targeting different disease manifestations and progression patterns.
Innovative research focusing on early-onset Parkinson's disease, examining long-term treatment efficacy and brain pathophysiology changes. Studies aim to understand disease progression and therapeutic interventions.
Emphasis on understanding disease mechanisms and developing targeted therapeutic solutions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.